Equbits, Health Discovery Settle SVM Infringement Suit
Health Discovery Corp. and Equbits have settled their patent-infringement suit, according to documents filed Oct. 26 with the US District Court for the Eastern District of Texas.
The dispute began in June when HDC sued Equbits and Ciphergen for allegedly infringing its support vector machine technology [BioInform 06-30-06]. HDC claims its technology is protected by US Patents 6,427,141; 6,760,715; and 6,789,069.
Terms of the settlement were not disclosed, and neither company responded to requests for comment.
In the suits HDC claimed that the companies market infringing products “to analyze protein expression data for discovery of biomarkers for use in diagnosis and treatment of disease, including various types of cancer.”
HDC cited Equbits’ Foresight software and Ciphergen's ProteinChip software, Biomarker Patterns software, and CiphergenExpress software as the infringing products.
The Ciphergen suit is still ongoing. Ciphergen filed a countersuit in September, along with a request for a change of venue from Texas to the US District Court for the Northern District of California [BioInform 09-22-06].
According to court documents filed Nov. 3, the parties have agreed that the “venue is not proper” in the Eastern District of Texas, but have not yet chosen a new venue.
Since August, Epigenomics and Bruker Daltonics have both licensed HDC’s support vector machine technology for use in life science applications.
Degussa-Led Systems Biology Consortium to Use Genedata Software
Genedata said this week that it has joined SysMAP, a joint industry and academic consortium led by chemicals maker Degussa that aims to increase the industrial production of amino acids.
Genedata said it will provide SysMAP, short for “systems-oriented analysis of the central metabolism of microbial amino acid producers,” with a computational framework for analyzing and structuring data based on its Phylosopher and Expressionist software.
The consortium will use the software to address problems in biotech production of chemicals for drugs, animal feed, and some foods, the company said.
Financial terms of the agreement were not provided.
Altair Joins SciTegic ISV Program to Integrate PBS Pro with Pipeline Pilot
Altair Engineering said this week that it has joined SciTegic's independent software vendor partner program in order to integrate its PBS Professional grid software with SciTegic’s Pipeline Pilot workflow platform.
Joint customers can use the two platforms together to run computational workloads across a grid managed by PBS Professional, Altair said.
Altair is the first grid technology provider under SciTegic’s ISV partner program.
"As deployments of Pipeline Pilot within research organizations have grown significantly, the efficient distribution and management of computationally intensive jobs submitted by individual users has turned out to be critical," said Mathew Hahn, vice president of platform strategy and technologies at Accelrys, SciTegic’s parent company.